Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07828457
NA

Interventional rTMS for Improving Social Perception in Autism

Sponsor: Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

Summary

Autism spectrum disorder (ASD) is a neurodevelopmental condition mainly characterized by difficulties in social interaction and social communication. Over the last 30 years, neuroimaging studies have identified anatomical and functional abnormalities localized in the superior temporal sulcus (STS) in individuals with ASD. The STS is a brain region that plays a central role in the perception and interpretation of social information. These findings make the STS a particularly relevant target for developing new therapeutic approaches aimed at improving social difficulties associated with ASD. The IRIS study aims to evaluate the effects of a non-invasive neuromodulation technique, transcranial magnetic stimulation (TMS), on social perception and social behavior in pre-adolescents and adolescents with ASD aged 10 to 17 years. The stimulation protocol, called intermittent theta-burst stimulation (iTBS), will target the right posterior STS. Previous studies conducted by the research team have established the feasibility and good tolerability of this approach in young adults with ASD. This is a randomized, double-blind, placebo-controlled clinical trial involving 16 participants and using a crossover design. Each participant will receive both active and placebo stimulation, in a randomized order, with an interval of approximately three months between the two periods. Each treatment period will consist of five sessions per day for four consecutive days, for a total of 20 sessions. The effects of the intervention on social perception and behavior will be objectively assessed using eye-tracking during the viewing of social scenes. Brain MRI will also be used to investigate potential changes in brain function, connectivity, and structure. In addition, clinical scales completed with the parents will be used to assess social behavior and overall functioning. The study will therefore determine whether an accelerated TMS protocol targeting a brain region involved in social cognition can improve social perception and behavior in young people with ASD, while also assessing its safety, tolerability, and effects on brain function.

Key Details

Gender

All

Age Range

10 Years - 17 Years

Study Type

INTERVENTIONAL

Enrollment

16

Start Date

2026-10

Completion Date

2029-01

Last Updated

2026-09-18

Healthy Volunteers

No

Interventions

DEVICE

Neuromodulation by transcranial magnetic stimulation (TMS)

2 series of 5 TMS applied each day, during 4 consecutive days : active or sham according randomization

RADIATION

Anatomo-functional MRI

For all patients, each MRI scan will include: * an ASL MRI to measure cerebral blood flow (CBF) at rest, * a resting-state functional MRI (rs-fMRI) to measure functional connectivity, * a diffusion-weighted MRI (DWI-MRI) to assess the microstructural integrity of the white matter. The total duration of each MRI scan will be approximately 30 minutes, and no injections or premedication will be used.

DEVICE

Eye-tracking

Eye-tracking technology records eye movements and tracks a participant's gaze while they view stimuli presented on a screen, by analyzing images of the eye captured by an infrared camera.

OTHER

Social Responsiveness Scale, Second Edition (SRS-2)

A Social Responsiveness Scale, Second Edition (SRS-2), Autism Behavior Checklist (ABC) and Clinical Global Impressions (CGI) will be used for assessment of Changes Induced by TMS on Social Behavior and Autistic Symptoms before the start of TMS sessions and during the 24 hours following the last stimulation session.

Locations (2)

Plateforme CENIR_PANAM au centre de Neuro Imagerie de recherche à l' " Institut du Cerveau " (ICM)

Paris, France

Hôpital Necker - Enfants Malades - Service de radiologie pédiatrique

Paris, France